Annual Congress of the Chinese Blood Purification Center Administration Committee. September 25-28, 2014, Guangzhou: Abstracts

Autor: Giovanni Grazi, Jicheng Zhang, Sampson Antwi, Jonathan M. Rubin, Leonardo C Ribeiro, Hanjie Zhang, Jing Gao, Gioacchino Li Cavoli, Susana Roca, Rainer Himmele, M. Ted Ferris, Paolo Armignacco, Alberto Rosati, Anna Meyring-Wösten, William J. Federspiel, Nefroint investigators, Fansan Zhu, Corinne E. Zeller-Knuth, Jose A. Diaz-Buxo, Gianluca Villa, April Bowman, Laura Bucalo, Grant H. Kruger, Marianne Wilhelmi, Daniel Muñoz-Aguayo, Sarah Cohen, Alberto A.E. Bertelli, Kristi Bickford, Aldo Casani, Mar Orzáez, Ekou Niamien, Emma Arcos, Jeremy D. Kimmel, Rafael de la Torre, Carmela Zagarrigo, Florence Desrosiers, Beatriz Santamaría, A. Mary Vilay, Michael J. Germain, María Ángeles García, Michael Heung, Jwa-Kyung Kim, Rinaldo Bellomo, Giovanni Manca Rizza, Karina Javalkar, Isaac Teitelbaum, Onofrio Schillaci, J. Michael Yardman-Frank, Juan Jesus Carrero, Laurence Adonis-Koffy, Gérard Abel, Len A. Usvyat, M. Valles, Marina Abramyan, Renhua Lu, Jordi Calabia, William F. Weitzel, Massimo Antonelli, Elizabeth A. Hughson, A. Phillips, John A. Kellum, Kyu Hun Choi, Khaled Abdel-Kader, Oleh Akchurin, Aileen Grassman, Pessa Albert Coulibaly, Jose J. Zaragoza, Alexandra Ternier, Jessica Cuttance, Krotenko Np, Michael J. Somers, Matteo Ruggeri, Alberto Ortiz, Claudio Ronco, Craig S. Wong, Ludimila Guedim de Campos, Maggie Han, María J. Vicent, Manuel Molina Nuñez, Frederick J. Kaskel, Angel Celdrán, Francesco Garzotto, Panduranga Rao, Roberto Bigazzi, Paul Zabetakis, Corrado Bellini, Druckerei Stückle, Mattia Palmeri, Alvaro C. Ucero, Cristina Jimeno, Aashish Sharma, Audie Métayer, Isabel Villegas, Sabrina Paoletti, Sarbjit V. Jassal, Donald Maberry, Stanley Fan, Massimiliano Migliori, Xiaoqi Xu, Maribel Covas, Jean Baptiste Yaokreh, Jacob Volpe, Peter Kotanko, Morton Satin, Maria E. Ferris, Popov Da, Marina Plyushch, Morgan Lam, Mathias Schaller, Keisha L. Gibson, Alberto Benito-Martin, Melissa Mendoza, Michail Yaroustovsky, Dalia Yousif, Anna Lorenzin, Keisha Gibson, Vincenzo Panichi, Sung Kyu Ha, Adriana Di Giorgio, Jordi Comas, Marco Sartori, Tancredi Vincenzo Li Cavoli, Hyeong Cheon Park, Karin True, Judith Exantus, Jean-Hénold Buteau, Sung Jin Moon, Gnenefoly Diarrassouba, Dorey A. Glenn, Sanah Parvez, Mark Unruh, Rasha Hussein, Mikhail Artemyev, Viviane Calice-Silva, Jung Eun Lee, Zhiyong Peng, Ugo Rotolo, Isa F. Ashoor, Montserrat Fitó, Alan Vollmer, María Soledad Ros, Hans Oberleithner, Alessandro Sgambato, Renee-Claude Mercier, James A. Hamilton, Nathan W. Levin, Alessia Scatena, Mauro Neri, Paul Balter, Gero von Gersdorff, Kenneth R. Wilund, Ekaterina Rogalskaya, Soo Young Yoon, Elizabeth Ley Oei, Joseph L. Bull, Roberto Pecoits-Filho, Danielle Marcelli, Paul K. Whelton, Franca Servillo, Michael Etter, Rosa de Alarcón, Xianglong Wang, Shin Wook Kang, Rafael Selgas, Gracia Álvarez, Mi Kyung Song, Kerry Anne Rambaran, Marta Ruiz-Ortega

Publikováno v: Blood Purification. 39:230-237

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::05d78e6d677803dbc9281eb041712867
https://doi.org/10.1159/000380930

Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients

Autor: Rafael Pérez-García, Stefano Sposini, Ciro Tetta, Massimiliano Migliori, Paolo Rindi, Giovanni Manca Rizza, Alessio Bertini, Vincenzo Panichi, Umberto Maggiore, D Taccola, Roberto Palla, Cristina Consani

Publikováno v: Nephrology Dialysis Transplantation. 19:1154-1160

Despite the well known association between interleukin-6 (IL-6) and cardiovascular mortality, no study has so far verified whether IL-6 adds prognostic information to that provided by C-reactive protein (CRP).A cohort of 218 haemodialysis patients fr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c46744e59a1adfeb1806f1f330c3c63a
https://doi.org/10.1093/ndt/gfh052

Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study

Autor: Giovanni Manca Rizza, Riccardo Giusti, E Mantuano, Giada Bernabini, Ciro Tetta, Alberto Lippi, Sara Beati, Vincenzo Panichi, Roberto Bigazzi, Massimiliano Migliori, Giovanni Grazi, Valentina Marchetti, Giuliano Barsotti, Aldo Casani, Alberto Rosati, Sabrina Paoletti

Publikováno v: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 26(8)

Resistance to erythropoiesis-stimulating agents (ESAs) is often associated with chronic inflammation. Here, we investigated how anaemia, ESA resistance and the plasma levels of biological markers of inflammation could influence all-cause and cardiova

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1fc61866f2c2f751c89c0d5743191e4
https://pubmed.ncbi.nlm.nih.gov/21602186

Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease

Autor: Vincenzo, Panichi, Emanuela, Mantuano, Sabrina, Paoletti, Samuele, Santi, Giovanni, Manca Rizza, Sebastiano, Cutrupi, Patrizia, Pizzini, Belinda, Spoto, Giovanni, Tripepi, Carmine, Zoccali

Publikováno v: Journal of nephrology. 21(1)

The endogenous inhibitor of nitric oxide (NO) synthase, asymmetric dimethylarginine (ADMA), is a strong cardiovascular (CV) risk marker in patients with chronic renal insufficiency. Statins have pleiotropic effects and are currently considered as pot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::507a34d395a015d0180bda3ea9fc43d2
https://pubmed.ncbi.nlm.nih.gov/18264935

Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients

Autor: Vincenzo, Panichi, Daniele, Taccola, Giovanni Manca, Rizza, Cristina, Consani, Massimiliano, Migliori, Cristina, Filippi, Sabrina, Paoletti, Antonino, Sidoti, Donella, Borracelli, Erica, Panicucci, Luca, Giovannini

Publikováno v: Journal of nephrology. 17(5)

The most frequent cause of death in hemodialysis (HD) patients is cardiovascular disease (CVD), and chronic inflammation has been identified as an epidemiologically important risk factor for CVD. Elevated levels of minor acute phase reactants, such a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::904d369c5be5c96690535ec190ea8563
https://pubmed.ncbi.nlm.nih.gov/15593040